Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
524322 KABRADG

Kabra Drugs Share Price

 

 

Kabra Drugs live price: ₹24.5.

Kabra Drugs Performance

  • Today's Low
  • ₹24
  • Today's High
  • ₹27
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹36
  • Open Price₹25
  • Previous Close₹0
  • Volume67,535
  • 50 DMA₹26.59
  • 100 DMA₹26.70
  • 200 DMA₹24.15

Kabra Drugs Chart

Investment Returns

  • Over 1 Month -8.95%
  • Over 3 Month -25.06%
  • Over 6 Month -9.35%
  • Over 1 Year + 110.06%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.5
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 58
  • P/B Ratio
  • 2
  • Average True Range
  • 1.97
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.57
  • RSI
  • 39.74
  • MFI
  • 56.18

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹24.50
+ 0.47 (1.96%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹25.50
  • 50 Day
  • ₹26.59
  • 100 Day
  • ₹26.70
  • 200 Day
  • ₹24.15

Resistance and Support

24.45 Pivot Speed
  • R3 28.15
  • R2 27.06
  • R1 25.54
  • S1 22.93
  • S2 21.84
  • S3 20.32

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-06 Others Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters.
2026-04-21 Others Inter-alia, to consider 1. Appointment of Ms. Monam Kapoor as Additional Director. 2. Board will discuss the amendment of the Main Objects clause of the MOA. 3. Notice of POM. 4.Other business matters
2026-03-07 Others Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters.
2026-02-13 Quarterly Results
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.

Kabra Drugs Shareholding Pattern

0%
90.92%
9.08%

Kabra Drugs FAQs

Kabra Drugs share price is ₹24 As on 22 May, 2026 | 12:01

The Market Cap of Kabra Drugs is ₹58.1 Cr As on 22 May, 2026 | 12:01

The P/E ratio of Kabra Drugs is 13.5 As on 22 May, 2026 | 12:01

The PB ratio of Kabra Drugs is 2 As on 22 May, 2026 | 12:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23